Korean J Obstet Gynecol.  2005 Jul;48(7):1673-1685.

Effects of the Specific COX-2 Inhibitor, Celecoxib, on Paclitaxel-Induced Apoptosis in SK-OV-3 Epithelial Ovarian Cancer Cell Line

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Kangwon National University, Chunchon, Korea. obypf@kangwon.ac.kr
  • 2Department of Pharmacology, College of Medicine, Kangwon National University, Chunchon, Korea.
  • 3Department of Obstetrics and Gynecology, Gachon Medical School, Incheon, Korea.

Abstract


OBJECTIVE
In vitro studies have revealed that treatment of various human cancer cell lines with specific cyclooxygenase 2 (COX-2) inhibitors induces apoptotic cell death. The goal of this article is to investigate the benefits of combining COX-2 inhibitors with existing treatment modalities in the management of ovarian cancer.
METHODS
In this study we sought to determine the effects of combining paclitaxel and the COX-2 inhibitor celecoxib on apoptosis of epithelial ovarian cancer (EOC) cells. SK-OV-3 cells were exposed to increasing concentrations of paclitaxel (10(-7) M, 10(-6) M and 10(-5) M) and celecoxib (10(-8) M, 10(-7) M, 10(-6) M, 10(-5) M and 10(-4) M) as well as a combination of both drugs. The activity of apoptosis was evaluated by the morphologic examination and the MTT assay. The pattern of apoptosis was also assessed by the caspase-3 activity and the fraction of cleaved PARP (poly ADP-ribose polymerase) protein.
RESULTS
Single application of both drugs could significantly increase the rate of apoptosis after 24 hours of continuous exposure. But concomitant treatment of SK-OV-3 EOC cell line with paclitaxel and celecoxib resulted in marked impairment of paclitaxel-induced apoptosis. The pattern of apoptosis induced by paclitaxel on SK-OV-3 EOC cell line was caspase-3 independent.
CONCLUSION
Combining COX-2 inhibitors and paclitaxel does not have an additive or synergistic tumoricidal effect. On the contrary, celecoxib treatment markedly inhibited the apoptotic effects of paclitaxel in SK-OV-3 EOC cell line.

Keyword

Ovarian cancer; Paclitaxel; Celecoxib; Apoptosis

MeSH Terms

Adenosine Diphosphate Ribose
Apoptosis*
Caspase 3
Cell Death
Cell Line*
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Humans
Ovarian Neoplasms*
Paclitaxel
Celecoxib
Adenosine Diphosphate Ribose
Caspase 3
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Paclitaxel
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr